Research Developments in Atopic Dermatitis

Dupilumab Treatment for up to Three Years Demonstrates Sustained Efficacy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Liberty AD Adult Open Label Extension

Listen Later

This poster was presented by Dr. Blauvelt and colleagues at the 2020 American Academy of Dermatology virtual annual meeting.

This over is provided by Dr. Steve Feldman.

...more
View all episodesView all episodes
Download on the App Store
Research Developments in Atopic DermatitisBy Annenberg Center for Health Sciences at Eisenhower

More shows like Research Developments in Atopic Dermatitis

View all
Derms and Conditions by Dermsquared

Derms and Conditions

52 Listeners